"Megestrol" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
17-Hydroxy-6-methylpregna-3,6-diene-3,20-dione. A progestational hormone used most commonly as the acetate ester. As the acetate, it is more potent than progesterone both as a progestagen and as an ovulation inhibitor. It has also been used in the palliative treatment of breast cancer.
| Descriptor ID |
D008535
|
| MeSH Number(s) |
D04.210.500.745.432.531
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Megestrol".
Below are MeSH descriptors whose meaning is more specific than "Megestrol".
This graph shows the total number of publications written about "Megestrol" by people in this website by year, and whether "Megestrol" was a major or minor topic of these publications.
![]()
To see the data from this visualization as text,
click here.
Below are the most recent publications written about "Megestrol" by people in Profiles.
-
Panwalker AP. Hyperglycemia induced by megestrol acetate. Ann Intern Med. 1992 May 15; 116(10):878.
-
Schlaff WD, Dugoff L, Damewood MD, Rock JA. Megestrol acetate for treatment of endometriosis. Obstet Gynecol. 1990 Apr; 75(4):646-8.
-
Muss HB, Wells HB, Paschold EH, Black WR, Cooper MR, Capizzi RL, Christian R, Cruz JM, Jackson DV, Powell BL, et al. Megestrol acetate versus tamoxifen in advanced breast cancer: 5-year analysis--a phase III trial of the Piedmont Oncology Association. J Clin Oncol. 1988 Jul; 6(7):1098-106.
-
Laucius JF, Patel YA, Lusch CJ, Koons LS, Bellet RE, Mastrangelo MJ. The phase II evaluation of Bacillus Calmette-Guerin plus megestrol acetate in patients with metastatic renal adenocarcinoma. Med Pediatr Oncol. 1977; 3(3):237-42.